Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$34.01 USD
-1.15 (-3.27%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $33.98 -0.03 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Return on Equity (TTM)
Legend Biotech Corporation Sponsored ADR's return on equity, or ROE, is -32.00% compared to the ROE of the Medical - Biomedical and Genetics industry of -66.95%. While this shows that LEGN has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
LEGN 34.01 -1.15(-3.27%)
Will LEGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Company News for Aug 12, 2025
Key Inflation Data in Focus
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
Other News for LEGN
Is LEGN lining up for a decline? Fell Below 20 Day Moving Average shows up after declining 3.27%
Is LEGN building bullish momentum? Crossed Above 20 Day Moving Average shows up after rising 2.0%
20 Day Moving Average Resistance appears for LEGN after 0.38% move
Is LEGN preparing to trend higher? MACD Bullish Signal Line Cross shows up after advancing 1.36%
Stochastic Buy Signal appears for LEGN after 2.33% move